Enzyme digestion conversion method of recombinant human insulin precursor

A technology of recombinant human insulin and conversion method, which is applied in the field of enzymatic conversion of insulin precursor and enzyme conversion of recombinant human insulin precursor, which can solve the problem of reduced sample yield, increased difficulty of sample purification, increased sample impurities, etc. problems, to achieve the effect of a single restriction site, improve conversion efficiency and simplify the production process

Pending Publication Date: 2021-04-09
SHANDONG EHUA BIOLOGICAL PHARMA +1
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patented technology helps improve the ability of humans's own beta cells (β cell) to break down their proteins into amino acids that are needed for growth or other functions like muscle contractions when they die due to lacking enough calories during exercise. By selecting specific types of cleavage enzymatic tools with fewer parts relative to traditional methods, this new approach simplifies the manufacturing processes while maintaining high levels of accuracy. Additionally, these techniques reduce complexity and simplify processing. Overall, this innovation provides better ways to produce biologically active agents such as hormones through genetic engineering rather than chemistry.

Problems solved by technology

Technological Problem: Current methods for producing high levels of glucose regulate blood sugar level through controlling various metabolites such as glycosaminoglutathione (GSH) sulfate and other substances like uricase activity during fasting periods. However, these techniques may also affect certain proteins involved in signal transductions between cells and tissues, leading to decreased accuracy when analyzed over time.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Enzyme digestion conversion method of recombinant human insulin precursor
  • Enzyme digestion conversion method of recombinant human insulin precursor
  • Enzyme digestion conversion method of recombinant human insulin precursor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] Embodiment 1 Enzymatic conversion of recombinant human insulin precursor

[0044] Take an appropriate amount of the recombinant human insulin precursor solution obtained from the initial purification, detect the sample concentration by high-performance liquid phase, calculate the volume V1 diluted to a concentration of 15g / L, add an appropriate amount of tris to mix well according to the volume, and make the final concentration 0.03mol / L (calculated according to the volume after dilution), measure the pH value, add an appropriate amount of purified water to adjust the volume of the sample solution to close to V1, adjust the pH to 9.0 with hydrochloric acid, and finally adjust the volume of the solution to V1;

[0045] Calculate the content of recombinant human insulin precursor protein, and then accurately weigh an appropriate amount of recombinant lysyl endopeptidase according to the ratio of recombinant lysyl endopeptidase: recombinant human insulin precursor = 1:1000 ...

Embodiment 2

[0048] Example 2 Enzymatic conversion of recombinant human insulin precursor

[0049] Take an appropriate amount of the recombinant human insulin precursor solution obtained from the initial purification, detect the sample concentration by high performance liquid phase, calculate the volume V2 diluted to a concentration of 10g / L, add an appropriate amount of borax according to the volume and stir well, so that the final concentration is 0.02mol / L (calculated according to the volume after dilution), measure the pH value, add an appropriate amount of purified water to adjust the volume of the sample solution to close to V2, adjust the pH to 9.4 with sodium hydroxide, and finally adjust the volume of the solution to V2;

[0050] Calculate the content of recombinant human insulin precursor protein, and then accurately weigh an appropriate amount of recombinant lysyl endopeptidase according to the ratio of recombinant lysyl endopeptidase: recombinant human insulin precursor = 1:1000...

Embodiment 3

[0053] Embodiment 3 Enzymatic conversion of recombinant human insulin precursor

[0054] Take an appropriate amount of the recombinant human insulin precursor solution obtained from the initial purification, detect the sample concentration by high-performance liquid phase, calculate the volume V3 diluted to a concentration of 20g / L, add an appropriate amount of tris hydroxymethyl aminomethane according to the volume and stir well to make the final concentration 0.02mol / L (calculated according to the volume after dilution), measure the pH value, add an appropriate amount of purified water to adjust the volume of the sample solution to close to V3, adjust the pH to 9.5 with hydrochloric acid or sodium hydroxide, and finally adjust the volume of the solution to V3;

[0055] Calculate the content of recombinant human insulin precursor protein, and then accurately weigh an appropriate amount of recombinant lysyl endopeptidase according to the ratio of recombinant lysyl endopeptidase...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an enzyme digestion conversion method of a recombinant human insulin precursor. The enzyme digestion conversion method comprises the following steps: (1) adding a primarily purified recombinant human insulin precursor solution into a buffer solution, and adjusting a concentration and a pH value to obtain an enzyme digestion reaction substrate mixed solution; and (2) adding recombinant lysyl endonuclease into the enzyme digestion reaction substrate mixed solution to carry out enzyme digestion conversion reaction on the recombinant human insulin precursor. The recombinant lysyl endonuclease is selected as a tool enzyme, and compared with common recombinant trypsin, the recombinant lysyl peptide endonuclease has advantages that less enzyme is needed by unit precursor protein, enzyme digestion site is single, enzyme digestion process is more efficient, and enzyme digestion conversion efficiency of a human insulin precursor reaches 95% or above; when enzyme digestion is amplified, worry about excessive enzyme digestion is avoided, and purity of target protein obtained after enzyme digestion is higher; the optimum pH range of enzyme digestion of the recombinant lysyl endonuclease is farther from pI of the protein before and after enzyme digestion, so that stability of the target protein is facilitated, and tolerance range to a salt concentration in the enzyme digestion environment is wider.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner SHANDONG EHUA BIOLOGICAL PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products